Fiscal Year 2025 (April 1, 2025 to March 31, 2026) Supplementary Materials (Consolidated IFRS)5/8 12:0TDnetPDF(750KB)
Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (IFRS)5/8 12:0TDnetPDF(504KB)
(Correction) Partial Correction to the ‘‘Notice concerning Disposal of Treasury Shares by Third-Party Allotment’’3/5 16:40TDnetPDF(137KB)
Notice concerning Introduction of Long-Term Incentive Stock Plan for Employees of Deciphera, the U.S. Subsidiary3/5 12:0TDnetPDF(151KB)
Announcement concerning the Transfer of Distribution Sales and Termination of Co-promotion for SGLT2 Inhibitor Forxiga 5 mg 10 mg in Japan2/27 16:0TDnetPDF(210KB)
Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2026 (IFRS)2/2 12:0TDnetPDF(371KB)
2nd Quarter of Fiscal Year 2025 (Ending March 31, 2026) (April 1, 2025 to September 30, 2025) Supplementary Materials (Consolidated IFRS)2025/10/30TDnetPDF(668KB)
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2026 (IFRS)2025/10/30TDnetPDF(471KB)
Notice concerning the Establishment of Ono Global Reinsurance, Inc. as an Overseas Subsidiary (Specified Subsidiary)2025/8/1TDnetPDF(135KB)
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026 (IFRS)2025/8/1TDnetPDF(921KB)
Notice on Completion of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation2025/7/18TDnetPDF(137KB)
Notice of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation2025/6/19TDnetPDF(160KB)